Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 22 04:00PM ET
0.6900
Dollar change
-0.1000
Percentage change
-12.66
%
Index- P/E- EPS (ttm)-1.25 Insider Own15.45% Shs Outstand15.98M Perf Week-25.81%
Market Cap12.61M Forward P/E- EPS next Y-1.00 Insider Trans47.00% Shs Float15.46M Perf Month-46.09%
Income-6.00M PEG- EPS next Q-0.46 Inst Own12.04% Short Float3.64% Perf Quarter-65.84%
Sales0.00M P/S- EPS this Y-6.92% Inst Trans- Short Ratio1.55 Perf Half Y-83.37%
Book/sh-0.37 P/B- EPS next Y28.06% ROA-33.38% Short Interest0.56M Perf Year-89.29%
Cash/sh0.05 P/C13.42 EPS next 5Y- ROE-202.12% 52W Range0.72 - 7.59 Perf YTD-88.21%
Dividend Est.- P/FCF- EPS past 5Y32.71% ROI- 52W High-90.91% Beta1.28
Dividend TTM- Quick Ratio0.82 Sales past 5Y0.00% Gross Margin- 52W Low-4.17% ATR (14)0.13
Dividend Ex-Date- Current Ratio0.82 EPS Y/Y TTM56.61% Oper. Margin0.00% RSI (14)28.73 Volatility14.92% 12.74%
Employees12 Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price18.00
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q134.04% Payout- Rel Volume1.83 Prev Close0.79
Sales Surprise- EPS Surprise120.00% Sales Q/Q- EarningsJun 17 BMO Avg Volume363.11K Price0.69
SMA20-30.82% SMA50-48.60% SMA200-78.83% Trades Volume660,775 Change-12.66%
Date Action Analyst Rating Change Price Target Change
Feb-14-22Initiated H.C. Wainwright Buy $25
Jul-18-24 07:56AM
Jun-14-24 09:52PM
Jun-03-24 08:00AM
May-30-24 08:00AM
May-28-24 08:00AM
07:27AM Loading…
07:27AM
May-24-24 08:00AM
May-21-24 07:39AM
May-17-24 04:33PM
May-15-24 08:00AM
Apr-24-24 08:00AM
Apr-10-24 08:00AM
Apr-09-24 08:00AM
Mar-19-24 06:52AM
Mar-07-24 08:00AM
08:00AM Loading…
Mar-06-24 08:00AM
Feb-27-24 08:00AM
Feb-07-24 08:00AM
Feb-06-24 08:30AM
Jan-30-24 10:48PM
Jan-04-24 08:45AM
Dec-28-23 08:55AM
Dec-20-23 08:40AM
Dec-06-23 09:31AM
09:00AM
Nov-30-23 07:00AM
Nov-03-23 08:31AM
Nov-01-23 10:49AM
Oct-25-23 09:15AM
Oct-20-23 09:15AM
09:00AM Loading…
Oct-18-23 09:00AM
Oct-11-23 09:10AM
Oct-04-23 09:00AM
Oct-03-23 09:00AM
Sep-08-23 07:00AM
Aug-31-23 11:54AM
08:21AM
Aug-25-23 02:33PM
Aug-18-23 12:21PM
Aug-16-23 08:36AM
Jul-10-23 07:00AM
Jun-27-23 08:05AM
May-25-23 09:00AM
May-19-23 11:38AM
May-15-23 08:00AM
Apr-27-23 05:33AM
Apr-17-23 07:45AM
Apr-10-23 07:29AM
Mar-30-23 08:45AM
Mar-15-23 09:15AM
Mar-14-23 06:27AM
Mar-09-23 04:56AM
Feb-23-23 08:00AM
Feb-11-23 07:13AM
Feb-09-23 11:09PM
Jan-24-23 09:07AM
Jan-23-23 12:06PM
08:41AM
Jan-20-23 12:15PM
Jan-18-23 08:47AM
Jan-10-23 09:00AM
Dec-19-22 06:16AM
Dec-08-22 09:25AM
Dec-02-22 10:00AM
Nov-30-22 08:04AM
Nov-21-22 05:10AM
Nov-15-22 08:00AM
Nov-10-22 09:00AM
Oct-31-22 07:54AM
Oct-21-22 09:00AM
Oct-14-22 07:13AM
Oct-12-22 09:00AM
Sep-28-22 09:15AM
Sep-14-22 09:20AM
Sep-07-22 09:25AM
Aug-17-22 10:13AM
Aug-05-22 02:41PM
Aug-04-22 09:00AM
Jul-21-22 08:23AM
Jul-05-22 09:00AM
Jun-29-22 09:00AM
Jun-24-22 09:00AM
Jun-23-22 07:40AM
May-18-22 09:15AM
May-06-22 03:02PM
Apr-13-22 08:00AM
Apr-12-22 04:30PM
Apr-07-22 08:30AM
Mar-29-22 05:44AM
Feb-28-22 08:00AM
Feb-23-22 08:00AM
Feb-16-22 08:00AM
Feb-11-22 04:12AM
Feb-10-22 11:00AM
08:00AM
Jan-19-22 04:57PM
Jan-11-22 09:00AM
Jan-05-22 05:15AM
Dec-29-21 08:48PM
Dec-16-21 08:00AM
BriaCell Therapeutics Corp. is an immuno-oncology biotechnology company, which engages in the development of immunotherapies for the treatment of cancer. Its technologies include Bria-IMT and Bria-OTS. The company was founded by Charles L. Wiseman and Isaac B. Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lustig MarcDirectorMay 14 '24Buy2.21902,9352,000,0012,542,935May 20 04:00 PM